Memantine can protect against inflammation-based cognitive decline in geriatric depression

Area of Science:

• Neuroscience
• Gerontology
• Psychiatry

Background:

• Geriatric depression often involves cognitive issues and inflammation, increasing risks for treatment resistance and dementia.
• Memantine, a neuroprotective agent, shows potential in improving depression, inflammation, and preventing cognitive decline.
• A prior clinical trial indicated escitalopram/memantine (ESC/MEM) improved mood and cognition over escitalopram/placebo (ESC/PBO).

Purpose of the Study:

• To investigate the impact of baseline inflammation on mood and cognitive outcomes in older adults with major depression.
• To examine whether escitalopram with memantine (ESC/MEM) offers protection against inflammation-associated cognitive decline compared to escitalopram with placebo (ESC/PBO).

Main Methods:

• A 6-month, double-blind, placebo-controlled trial involving 90 adults (≥60 years) with major depression and memory complaints.
• Measurement of inflammatory cytokine markers using a Human 38-plex magnetic cytokine/chemokine kit.
• Analysis of four derived cytokine factors and linear models to assess predictive ability on depression and cognition changes.

Main Results:

• Sixty-two participants completed the study; both groups showed significant depression improvement (HAM-D score).
• No significant cognitive outcome improvements were observed in either group at six months.
• Baseline pro-inflammatory biomarkers predicted executive function decline in the ESC/PBO group, but not in the ESC/MEM group (interaction p=.04).

Conclusions:

• The addition of memantine to escitalopram demonstrated a protective effect on executive functioning in older adults with depression.
• This exploratory analysis suggests memantine may mitigate the negative impact of inflammation on cognition in this population.
• Further research is warranted to confirm the association between cytokine markers and treatment-induced cognitive changes in geriatric depression.